Search filters

List of works by Jacoline Bouvy

All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe

scientific article published on 01 September 2019

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe

scientific article

Benefit-risk reassessment of medicines: a retrospective analysis of all safety-related referral procedures in Europe during 2001-2012.

scientific article published on 4 May 2016

Epidemiology of adverse drug reactions in Europe: a review of recent observational studies

scientific article published on May 2015

Health Technology Assessment in the Context of Adaptive Pathways for Medicines in Europe: Challenges and Opportunities

scientific article published on 17 October 2016

Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013.

scientific article published on 26 March 2017

Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease

article

The Costs and Effects of Post-Authorisation Safety Studies For New Active Substances

scientific article published on 26 October 2014

The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies.

scientific article published on 28 December 2011

The cost-effectiveness of periodic safety update reports for biologicals in Europe

scientific article published on 24 January 2013

Use of Patient Preference Studies in HTA Decision Making: A NICE Perspective

scientific article published on 01 April 2020

Value for money of drug regulation

scientific article published on 01 June 2012

Paulina is supported by:

About Paulina

Help